FREE Account Opening + No Clearing Fees
Loading...

Natco Pharma Buyback 2023 vs TeamLease Services Buyback

Comparision between Natco Pharma Buyback 2023 and TeamLease Services Buyback.

Buyback Details

Natco Pharma Buyback 2023 is a Open Market Through Stock Exchange buyback proposed to list at BSE, NSE while TeamLease Services Buyback is a Tender Offer proposed to list at BSE, NSE.

  Natco Pharma Limited TeamLease Services Limited
Logo Natco Pharma Buyback 2023 Logo TeamLease Services Buyback Logo
Type of Buyback Open Market Through Stock Exchange Tender Offer
Listing At BSE, NSE BSE, NSE
Face Value ₹2 per share ₹10 per share
Buyback Price ₹700 per share ₹3050 per share
Issue Size 3,27,869 shares
Issue Size (Amount) ₹210.00 Crores ₹100.00 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders1 Equity Shares out of every 6 Fully paid-up Equity Shares held on the Record Date.49,181.00
General Category for all other Eligible Shareholders1 Equity Shares out of every 60 Fully paid-up Equity Shares held on the Record Date.278,688.00
Registrar Venture Capital And Corporate Investments Pvt Ltd Kfin Technologies Limited
Lead Managers Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Edelweiss Financial Services Ltd
Necessity of the buyback

The Buyback is being undertaken for the following reasons:

  1. The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares
  2. The Buyback may help in improving return on equity, by the reduction in the equity base.
  3. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.

The Buyback is being undertaken for the following reasons:

  1. The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares.
  2. The buyback consists of a reservation for the small shareholder. The company believes that this reservation for small shareholders would benefit a large number of public shareholders who would get classified as "small shareholders".
  3. The buyback may help in improving return on equity, by a reduction in the equity base, thereby leading to a long-term increase in shareholders' value.
  4. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.
  5. The buyback may lead to a reduction in outstanding Equity shares, an improvement in earnings per equity share, and an enhanced return on invested capital.

Buyback Timetable

Natco Pharma Buyback 2023 and TeamLease Services Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Natco Pharma Buyback 2023 Buyback record date is . TeamLease Services Buyback Buyback record date is Apr 03, 2023.

  Natco Pharma Limited TeamLease Services Limited
Record Date Apr 03, 2023
Offer Open Date Mar 21, 2023 May 12, 2023
Offer Closure Date May 12, 2023 May 25, 2023
Last date for receipt of tender forms May 25, 2023
Finalisation of buyback Jun 02, 2023
Last Date for settlment of bids Jun 05, 2023
Last Date for extinguishment of shares Jun 12, 2023

Financial Details and Other Relevent Information

Comparison of Natco Pharma Buyback 2023 and TeamLease Services Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Natco Pharma Limited TeamLease Services Limited
Financial
Natco Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal RevenueProfit After TaxNet Worth
31-Mar-202,022.40458.103,773.50
31-Mar-212,155.70442.404,121.60
31-Mar-222,043.80170.004,263.60
31-Dec-221,884.80439.504,628.20
Amount in ₹ Crore
TeamLease Services Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-205,231.5734.98
31-Mar-211,310.794,916.1878.47
31-Mar-221,540.416,499.5539.45
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 554.95 502.00 535.04
Jan-2023 570.40 526.00 545.28
Dec-2022 599.00 548.00 565.78

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 2570.05 2225.95 2465.23
Jan-2023 2584.00 2172.00 2446.89
Dec-2022 2598.15 2435.00 2514.93
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 555.00 502.00 534.88
Jan-2023 570.00 526.10 545.36
Dec-2022 600.00 547.50 565.78

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 2594.90 2216.00 2463.17
Jan-2023 2585.00 2172.30 2447.11
Dec-2022 2586.50 2430.00 2515.89

Comments

Add a public comment...